Sirdalud

Sirdalud Overdosage

tizanidine

Manufacturer:

Novartis Healthcare

Distributor:

Zuellig

Marketer:

Sandoz
Full Prescribing Info
Overdosage
In the few reports of drug overdosage received, recovery was uneventful, including by a patient who ingested 400 mg tizanidine (Sirdalud).
Symptoms: Nausea, vomiting, hypotension, QT(c) prolongation, dizziness, somnolence, miosis, restlessness, respiratory distress, coma.
Treatment: It is recommended to eliminate the ingested drug by repeated administration of high doses of activated charcoal. Forced diuresis is expected to accelerate the elimination of the drug. Further treatment should be symptomatic.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in